-
-
Ocrelizumab (Ocrevus®) accepted for use in PPMS within NHS Scotland
-
Posted in Industry News
-
14th Jan 2020
-
Industry news from Roche
Posted in Industry News
14th Jan 2020
Industry news from Roche
Posted in Industry News
10th Dec 2019
Those of us in the room have the power we need to fundamentally improve the quality of multiple sclerosis (MS) care in the UK, reduce variation and offer consistent care at the level we want everywhere, in the next 3 years. In July, 85% of 120 healthcare professionals agreed with this statement (‘Raising the Bar’, […]
Posted in Industry News
05th Dec 2019
Industry news: patients with highly active MS will now have access to cladribine tablets without the additional requirement of a gadolinium-enhanced MRI, following review from NICE.
Posted in Industry News
22nd Oct 2019
News from Merck
Posted in Rehabilitation Articles
01st Oct 2019
Rachel Farrell and David Baker
Posted in Industry News
13th Sep 2019
News from Biogen at #ECTRIMS19
Posted in Industry News
13th Sep 2019
News of Mavenclad from #ECTRIMS19
Posted in Industry News,Neurology News
30th May 2019
Campaign to encourage interaction of PwMS with services
Posted in Sponsored Feature,Supplements
07th May 2019
This article was initiated, developed and funded by Merck
Posted in Courses & Conferences
04th Mar 2019
Preview: n educational meeting organised and funded by Teva UK Limited, open to Consultants, Nurses and Specialist Registrars with an interest in Multiple Sclerosis